Prediction of the efficacy of first transarterial chemoembolization for advanced hepatocellular carcinoma via a clinical-radiomics model

Table 6 Comparison between the training and validation cohorts of the radiomics models

Model	Training cohort (n = 85)				Validation cohort (n = 37)
	AUC	95%CI	Sensitivity%	Specificity%	AUC	95%CI	Sensitivity%	Specificity%
Arterial phase	0.885	0.814-0.955	0.829	0.613	0.592	0.400-0.783	0.476	0.428
Venous phase	0.867	0.790-0.940	0.863	0.686	0.755	0.600-0.910	0.818	0.533
Arteria + venous phase	0.84	0.758-0.923	0.823	0.657	0.645	0.461-0.829	0.590	0.467
Peritumor 5- mm (venous phase)	0.866	0.791-0.941	0.863	0.656	0.594	0.402-0.786	0.591	0.667
Peritumor 10- mm (venous phase)	0.922	0.866-0.977	0.921	0.686	0.603	0.408-0.799	0.682	0.467

AUC: Area under the curve.